Atlas Trials

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL

Clinical trial NCT01914744 · UNKNOWN

Trial details

NCT number
NCT01914744
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin LymphomaHepatitis B Reactivation
Start date
2013-02-01
Primary completion
2015-12-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.